Procurement of medicines for 2026 Biological therapy
- Published
- 17 June 2026
- Place of performance
- MKZZZ
- Documents
- 1
- Notice number
- 00414635-2026
- Reference
- 72c5d95d-54bc-45a4-ac00-29b1f465908a
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Procurement of medicines for 2026 Biological therapy
Lots (2)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | L01FG01 Bevacizumab biosimilar 400 mg/16 ml | 33600000 Pharmaceutical products | — |
| 2 | L01EX27 Capivasertib 200mg | 33600000 Pharmaceutical products | — |
Official publications
- TED · 00414635-2026 · 17 June 2026
- OJS · 115/2026 · 17 June 2026
Other tenders from University clinic of radiotherapy and oncology
- Procurement of medical supplies
- Full service (regular maintenance and interventional servicing) for therapy machines
- Laboratory reagents and materials
- Drugs that are registered and on the positive list
- Equipment for Brachy therapy
- Procurement of medicines for 2026 Biological therapy
- Laboratory reagents and materials
- Laboratory reagents and materials
- Medicines
- Halcyon MV System Linear Accelerator Service
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is University clinic of radiotherapy and oncology (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.